Intravitreal Triamcinolone Acetonide Compared With Bevacizumab for the Treatment of Patients With Macular Edema Secondary to Central Retinal Vein Occlusion

References

• . Tao Y, Hou J, Jiang YR, Li XX, Jonas JB. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Eye (Lond). 2010;24(5):810–815
   PubMedGoogle Scholar
• . Wu WC, Cheng KC, Wu HJ. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion. Eye (Lond). 2009;23(12):2215–2222
   PubMedGoogle Scholar
• . Finkelstein D. Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol. 1992;110(10):1427–1434
   PubMedGoogle Scholar
• . Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group [published correction appears m Arch Ophthalmol. 1997;115(10)1275]. Arch Ophthalmol. 1997;115(4):486–491
   PubMedGoogle Scholar
• . Ferris FL 3rd, Miller KM, Glassman AR, Beck RW; Diabetic Retinopathy Clinical Research Network. A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical research. Ophthalmology. 2010;117(8):1512–1516
   PubMedGoogle Scholar
• . Browning DJ, Glassman AR, Aiello LP, ; Diabetic Retinopathy Clinical Research Network. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology. 2008;115(8):1366–1371
   PubMedGoogle Scholar
• . Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol. 2006;124(2):193–198
   PubMedGoogle Scholar
• . Cheng KC, Wu WC, Chen KJ. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion. Eye (Lond). 2009;23(11):2023–2033
   PubMedGoogle Scholar
• . Cheng KC, Wu WC. Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion. Kaohsiung J Med Sci. 2006;22(7):321–330
   PubMedGoogle Scholar
• . Ip MS, Gottlieb JL, Kahana A, . Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol. 2004;122(8):1131–1136
   PubMedGoogle Scholar
• . Priglinger SG, Wolf AH, Kreutzer TC, . Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial. Retina. 2007;27(8):1004–1012
   PubMed Web of Science ®Google Scholar
• . Pournaras JA, Nguyen C, Vaudaux JD, Konstantinidis L, Ambresin A, Wolfensberger T. Treatment of central retinal vein occlusion-related macular edema with intravitreal bevacizumab (Avastin): preliminary results. Klin Monbl Augenheilkd. 2008;225(5):397–400
   PubMedGoogle Scholar
• . Rensch F, Jonas JB, Spandau UH. Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion. Acta Ophthalmol. 2009;87(1):77–81
   PubMed Web of Science ®Google Scholar
• . Krepier K, Ergun E, Sacu S, . Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion. Acta Ophthalmol Scand. 2005;83(1):71–75
   PubMedGoogle Scholar
• . Moschos MM, Moschos M. Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study. Doc Ophthalmol. 2008;116(2):147–152
   PubMedGoogle Scholar
• . Gelston CD, Olson JL, Mandava N. Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone. Acta Ophthalmol Scand. 2006;84(3):314–318
   PubMedGoogle Scholar
• . Gregori NZ, Rosenfeld PJ, Puliafito CA, . One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion. Retina. 2006;26(8):889–895
   PubMedGoogle Scholar
• . Lim JW, Na KI. A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision. Indian J Ophthalmol. 2011;59(2):93–96
   PubMedGoogle Scholar
• . Wang L, Song H. Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion. Acta Ophthalmol. 2009;87(3):285–289
   PubMedGoogle Scholar
• . Kriechbaum K, Michels S, Prager F, . Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol. 2008;92(4):518–522
   PubMedGoogle Scholar
• . Hsu J, Kaiser RS, Sivalingam A . Intravitreal bevacizumab (avastin) in central retinal vein occlusion. Retina. 2007;27(8):1013–1019
   PubMed Web of Science ®Google Scholar
• . Guthoff R, Meigen T, Hennemann K, Schrader W. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to central retinal vein occlusion—a matched-pairs analysis. Ophthalmologica 2010;224(2):126–132
   PubMedGoogle Scholar
• . Scott IU, Ip MS, Van Veldhuisen PC, ; SCORE Study Research Group. Arandomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6 [published correction in Arch Ophthalmol. 2009;127(12):1655]. Arch Ophthalmol. 2009;127(9):1115–1128
   PubMedGoogle Scholar
• . Ip MS, Scott IU, Van Veldhuisen PC, ; SCORE Study Research Group. Arandomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5 [published correction in Arch Ophthalmol. 2009;127(12):1648]. Arch Ophthalmol. 2009;127(9):1101–1114
   PubMedGoogle Scholar
• . Yeh WS, Haller JA, Lanzetta P, . Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology. 2012;119(6):1190–1198
   PubMed Web of Science ®Google Scholar
• . Hatef E, Khwaja A, Rentiya Z, . Comparison of time domain and spectral domain optical coherence tomography in measurement of macular thickness in macular edema secondary to diabetic retinopathy and retinal vein occlusion. J Ophthalmol. 2012;2012:354783
   PubMed Web of Science ®Google Scholar